High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis

High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis

Abstract Background Migraine and depression are highly prevalent and partly overlapping disorders that cause strong limitations in daily life. Patients tend to respond poorly to the therapies available for these diseases. OnabotulinumtoxinA has been proven to be an effective treatment for both migra...

Full description

Bibliographic Details
Main Authors: Oreste Affatato, Thiago C. Moulin, Claudia Pisanu, Victoria S. Babasieva, Marco Russo, Elif I. Aydinlar, Paola Torelli, Vladimir N. Chubarev, Vadim V. Tarasov, Helgi B. Schiöth, Jessica Mwinyi
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Journal of Translational Medicine
Subjects:
OnabotulinumtoxinA
Botox
Migraine
Depression
Meta-analysis
Online Access:https://doi.org/10.1186/s12967-021-02801-w

Internet

https://doi.org/10.1186/s12967-021-02801-w

Similar Items